NFKB1 and chronic kidney disease: In the present study, JPYS improved the insufficiency of Nrf2 and its downstream targets in CKD rats and mitigated infiltration of inflammatory cells, suggesting that the JPYS formula also has an anti-inflammatory effect by activating Nrf2 signaling through suppressing the NF-κB pathway.